The Retina Foundation of the Southwest, established in 1975, is a 501(c)(3) nonprofit vision research institute dedicated to preventing vision loss and restoring sight through innovative research and treatment. Our scientists are leading the way the world understands, prevents, …
Read MoreThe Retina Foundation is pioneering research to develop new technologies to prevent vision loss and restore sight through early detection and treatment of AMD. Our approach is integrating the expertise of scientists, medical doctors and engineers to create cutting-edge treatments to meet the direct needs of patients affected by AMD...
Click Here To Learn MoreOur research aims to improve vision for children affected by pediatric eye conditions. Vision loss during childhood can impact a child's ability to learn important skills for growth, development and independence. 60% of the patients served by the Retina Foundation are children...
Click Here To Learn MoreWe are world renowned for 37 years of translational research in retinal degeneration, where discoveries in the laboratory are directly transferred to patients in clinical studies. Biotech and pharmaceutical companies partner with the Retina Foundation because of our expertise in clinical trial procedures, which in turn accelerates the delivery of treatments to the patients who need it...
Click Here To Learn MoreRead the stories about our advances in research and learn about the successes of the people who are impacted by the sight-saving research at the Retina Foundation of the Southwest.
View All News
April 8, 2019 The Retina Foundation of the Southwest acquired and renovated a new clinical research center in Dallas, Texas thanks to tremendous help from the Board of Directors and generous support from foundations, companies, and individuals. Join us at …
March 18, 2019 Since 1982, the Retina Foundation of the Southwest has been researching pediatric eye conditions to help infants and children with lazy eye, crossed eyes, cataracts, and other conditions. On March 18, 2019, our 10,000th patient completed his …
